Disclosure Of First-Time Adoption [Text Block]

RaySearch Laboratories - Filing #5870868

Concept	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	—	856 929 SEK	—	17 141 SEK	662,000 SEK	—	876 707 SEK	—	1 975 SEK	876 707 SEK	—	735 232 SEK	—	721 982 SEK	—	—	17 141 SEK	5 866 SEK	735 232 SEK	1 975 SEK	640 410 SEK	17 141 SEK	2 370 SEK	657 156 SEK	1 975 SEK
Comprehensive income	210 041 SEK	—	6 528 SEK	—	—	203 513 SEK	—	210 041 SEK	—	—	78 076 SEK	—	78 076 SEK	—	81 572 SEK	3 496 SEK	—	—	—	—	—	—	—	—	—
Profit (loss)	203 513 SEK	—	—	—	—	203 513 SEK	—	203 513 SEK	—	—	81 572 SEK	—	81 572 SEK	—	81 572 SEK	—	—	—	—	—	—	—	—	—	—